2018
DOI: 10.3325/cmj.2018.59.203
|View full text |Cite
|
Sign up to set email alerts
|

Transplantation of neural stem cells in the mouse model of ischemic brain stroke and expression of genes involved in programmed cell death

Abstract: AimTo analyze how neural stem cells (NSC) transplantation in the stroke-affected mouse brain influences the expression of genes involved in apoptosis-inducing factor (AIF)-mediated cell death – apoptosis inducing factor mitochondria associated 1 (Aifm1), ring finger protein 146 (Rnf146, Iduna), and cyclophilin A (CypA); necroptosis –receptor interaction protein kinase 1 (Ripk1), Ripk3, and mixed-lineage kinase domain-like protein (Mlkl); and apoptosis – Caspase 3 (Casp3) and Casp8.MethodsFour groups of animals… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 34 publications
0
2
0
Order By: Relevance
“…Interestingly, we found that neural stem cell transplantation, but also enriched medium, significantly down-regulated Ripk 1. At the same time, neural stem cells did not influence Ripk3 and Mlkl levels, which remains to be explained (24).…”
Section: Inhibition Of Necroptosis Is Protective In Ischemic Brain Inmentioning
confidence: 89%
“…Interestingly, we found that neural stem cell transplantation, but also enriched medium, significantly down-regulated Ripk 1. At the same time, neural stem cells did not influence Ripk3 and Mlkl levels, which remains to be explained (24).…”
Section: Inhibition Of Necroptosis Is Protective In Ischemic Brain Inmentioning
confidence: 89%
“…We wanted to fill the existing gaps by organizing sessions with experts dealing with a particular group of brain diseases or strategies from various angles. For example, amyotrophic lateral sclerosis or stroke can be addressed from the point of view of neuropathology, diagnostics, or neuroinflammation; from the point view of various types of cell death; but also from the point of view of assisted ventilation in the last weeks of patient’s life (3). Every disease can and should be seen from a united point of view: a preclinical scientist is expert in molecular mechanisms and tools to control them, but does not know in what form and when clinical practitioners would require such data.…”
mentioning
confidence: 99%